Avelumab as second-line or later treatment in patients with metastatic Merkel cell carcinoma: Analysis of real-world outcomes in France using the CARADERM database linked to the French national healthcare database

Bibliographic Details
Title:	Avelumab as second-line or later treatment in patients with metastatic Merkel cell carcinoma: Analysis of real-world outcomes in France using the CARADERM database linked to the French national healthcare database
Authors:	Mortier, Laurent, Blom, Astrid, van Hille, Benoît, Samimi, Mahtab, Luciani, Laura, Cahuzac, Capucine, Robert, Caroline, Quereux, Gaelle, Maubec, Eve, Miotti, Hakima, Maillard, Cathy, Aubin, François, Lenormand, Cédric, Solbes, Marie-Noëlle, Joly, Pascal, Kachaner, Isabelle, Lebbé, Céleste, Dutriaux, Caroline, Saiag, Philippe
Source:	In European Journal of Cancer September 2024 209
Database:	ScienceDirect